Your browser doesn't support javascript.
loading
Impact of anti-CD20 monoclonal antibodies on serologic response to BNT162b2 vaccine in B-cell Non-Hodgkin's lymphomas.
Marchesi, Francesco; Pimpinelli, Fulvia; Giannarelli, Diana; Ronchetti, Livia; Papa, Elena; Falcucci, Paolo; Pontone, Martina; Di Domenico, Enea Gino; di Martino, Simona; Laquintana, Valentina; Mandoj, Chiara; Conti, Laura; Cordone, Iole; La Malfa, Antonia; Viggiani, Caterina; Renzi, Daniela; Palombi, Francesca; Romano, Atelda; Pisani, Francesco; Gumenyuk, Svitlana; Di Bella, Ornella; Vujovic, Branka; Morrone, Aldo; Ciliberto, Gennaro; Ensoli, Fabrizio; Mengarelli, Andrea.
Affiliation
  • Marchesi F; Hematology Unit, Department of Research and Clinical Oncology, IRCCS Regina Elena National Cancer Institute, Rome, Italy. francesco.marchesi@ifo.gov.it.
  • Pimpinelli F; Microbiology and Virology Unit, Dermatological Clinical and Research Department, IRCCS San Gallicano Institute, Rome, Italy.
  • Giannarelli D; Clinical Trial Center, Biostatistics and Bioinformatics Unit, Scientific Direction, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Ronchetti L; SAFU Unit, Department of Research and Innovative Technologies, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Papa E; Hematology Unit, Department of Research and Clinical Oncology, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Falcucci P; Hematology Unit, Department of Research and Clinical Oncology, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Pontone M; Microbiology and Virology Unit, Dermatological Clinical and Research Department, IRCCS San Gallicano Institute, Rome, Italy.
  • Di Domenico EG; Microbiology and Virology Unit, Dermatological Clinical and Research Department, IRCCS San Gallicano Institute, Rome, Italy.
  • di Martino S; Biological Tissue and Liquid Bank, Scientific Direction, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Laquintana V; Biological Tissue and Liquid Bank, Scientific Direction, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Mandoj C; Clinical Pathology and Cancer Biobank, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Conti L; Clinical Pathology and Cancer Biobank, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Cordone I; Clinical Pathology and Cancer Biobank, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • La Malfa A; Pharmacy Unit, Medical Direction, IRCCS Regina Elena National Cancer Institute and San Gallicano Institute, Rome, Italy.
  • Viggiani C; Hematology Unit, Department of Research and Clinical Oncology, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Renzi D; Hematology Unit, Department of Research and Clinical Oncology, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Palombi F; Hematology Unit, Department of Research and Clinical Oncology, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Romano A; Hematology Unit, Department of Research and Clinical Oncology, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Pisani F; Hematology Unit, Department of Research and Clinical Oncology, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Gumenyuk S; Hematology Unit, Department of Research and Clinical Oncology, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Di Bella O; Medical Direction, IRCCS Regina Elena National Cancer Institute and San Gallicano Institute, Rome, Italy.
  • Vujovic B; Medical Direction, IRCCS Regina Elena National Cancer Institute and San Gallicano Institute, Rome, Italy.
  • Morrone A; Scientific Direction, IRCCS San Gallicano Institute, Rome, Italy.
  • Ciliberto G; Scientific Direction, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Ensoli F; Microbiology and Virology Unit, Dermatological Clinical and Research Department, IRCCS San Gallicano Institute, Rome, Italy.
  • Mengarelli A; Hematology Unit, Department of Research and Clinical Oncology, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
Leukemia ; 36(2): 588-590, 2022 02.
Article in En | MEDLINE | ID: mdl-34545184
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Non-Hodgkin / Lymphoma, B-Cell / Antigens, CD20 / COVID-19 / BNT162 Vaccine / Antibodies, Monoclonal Type of study: Observational_studies / Prognostic_studies Limits: Aged / Aged80 / Female / Humans / Male Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2022 Document type: Article Affiliation country: Italia
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Non-Hodgkin / Lymphoma, B-Cell / Antigens, CD20 / COVID-19 / BNT162 Vaccine / Antibodies, Monoclonal Type of study: Observational_studies / Prognostic_studies Limits: Aged / Aged80 / Female / Humans / Male Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2022 Document type: Article Affiliation country: Italia